SCOPUS 정보 검색 플랫폼

Science

Volumn 245, Issue 4917, 1989, Pages 519-522

The effect of deprenyl (selegiline) on the natural history of Parkinson's disease

(2) Tetrud, James W a Langston, J William a

a PARKINSON S INSTITUTE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SELEGILINE;

CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; AGED; CLINICAL TRIALS; DOUBLE-BLIND METHOD; FEMALE; HUMAN; LEVODOPA; MALE; MIDDLE AGE; MONOAMINE OXIDASE INHIBITORS; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; PHENETHYLAMINES; PYRIDINES; RANDOM ALLOCATION; SELEGILINE; SUPPORT, NON-U.S. GOV'T;

EID: 0024343466 PISSN: 00368075 EISSN: None Source Type: Journal
DOI: 10.1126/science.2502843 Document Type: Article

Times cited : (593)

References (31)

1
- 0006117895
- J. Jankovic and E. Tolosa, Eds. Urban and Schwarzenberg, Baltimore-Munich
- (1988) Parkinson's Disease and Movement Disorders , pp. 95-119
- Jankovic, J.¹ Marsden, C.D.²

2
- 0020683252
- (1983) Mod. Probi. Pharmacopsychiatr. , vol.19 , pp. 170
- Birkmayer, W.¹

3
- 0020680904
- (1983) Science , vol.219 , pp. 979
- Langston, J.W.¹

4
- 84967827762
- (1983) Proc. Natl. Acad. Sci. U.S.A. , vol.80 , pp. 4546
- Bums, R.S.¹

5
- 0021337873
- (1984) Brain Res. , vol.292 , pp. 390
- Langston, J.W.¹

6
- 0021276089
- (1984) Biochem. Biophys. Res. Commun. , vol.120 , pp. 574
- Chiba, K.¹ Trevor, A.J.² Castagnoli, N.³

7
- 0021263249
- (1984) Neurosci. Lett. , vol.48 , pp. 87
- Langston, J.W.¹

8
- 0021137683
- (1984) Nature , vol.311 , pp. 464
- Markey, S.P.¹

9
- 0021182244
- (1984) Science , vol.225 , pp. 1480
- Langston, J.W.¹ Irwin, I.² Langston, E.B.³ Forno, L.S.⁴

10
- 0021224694
- (1984) Nature , vol.311 , pp. 467
- Heikkila, R.E.¹ Manzino, L.² Duvoisin, R.C.³ Cabbat, F.S.⁴

11
- 0021712735
- (1985) Eur.J. Pharmacol. , vol.106 , pp. 209
- Cohen, G.¹

12
- 0023473938
- (1987) J. Neural. Transm. [Suppl] , vol.25 , pp. 69
- Tetrud, J.W.¹ Langston, J.W.²

13
- 0016823810
- (1975) J. Psychiatr. Res. , vol.12 , pp. 189
- Folstein, M.F.¹ Folstein, S.E.² McHugh, P.R.³

14
- 0000224448
- S. Fahn, C. D. Marsden, D. B. Calne, M. Goldstein, Eds. MacMillan Healthcare information, Florham Park, NJ
- (1987) Members of the UPDRS Development Committee, in Recent Developments in Parkinson's Disease , vol.2 , pp. 153-163
- Fahn, S.¹ Elton, R.L.²

15
- 0002554299
- M. B. Stem and H. I. Hurtig, Eds. PMA, New York
- (1988) The Comprehensive Management of Parkinson's Disease , pp. 3-50
- Stem, M.B.¹

16
- 0014082977
- For this study, the Hoehn and Yahr scale was slightly modified: stage 1, unilateral disease; stage 1.5, unilateral disease with neck rigidity; stage 2, bilateral disease without impaired balance; stage 2.5, bilateral disease with impaired balance after being pushed, but able to regain balance without assistance
- (1967) Neurology , vol.17 , pp. 427
- Hoehn, M.¹ Yahr, M.D.²

17
- 0014261678
- (1968) Mod. Treat. , vol.5 , pp. 257
- Webster, D.D.¹

18
- 0001265104
- F. J. Gillingham and M. C. Donaldson, Eds. Livingstone, Edinburgh
- (1969) Third Symposium on Parkinson's Disease , pp. 152-157
- Schwab, R.S.¹ England, A.C.²

19
- 0005330204
- Wiley, New York
- (1980) Biostatistics Case Book
- Miller, R.G.¹ Efron, B.² Brown, B.W.³ Moses, L.E.⁴

20
- 0022713585
- (1986) Stat. Med. , vol.5 , pp. 211
- Brown, B.W.¹ Halpern, J.²

21
- 0022496317
- (1986) J. Neurochem. , vol.46 , pp. 1359
- Reiderer, P.¹ Youdim, M.B.H.²

22
- 0020997395
- (1983) Acta Neurol. Scand. Suppl. , vol.95 , pp. 57
- Knoll, J.¹

23
- 0017863880
- Since deprenyl and its metabolites are cleared within 24 to 48 hours after stopping the drug, the only pharmacologic effect that might be long-lasting is its action on MAO B, as it binds irreversibly to this enzyme. However, replacement synthesis results in a gradual return of MAO B activity within 2 to 3 weeks. Therefore, the washout period of 1 month should have been fully adequate to detect a transient dopaminomimetic effect, had there been one
- (1978) Psychopharmacology , vol.57 , pp. 33
- Elsworth, J.D.¹

24
- 0004248046
- Wiley, New York
- (1981) Survival Analysis
- Miller, R.¹

25
- 0024585244
- (1989) Arch. Gen. Psychiatry , vol.46 , pp. 45
- Mann, J.J.¹

26
- 0022345867
- (1985) Science , vol.230 , pp. 527
- Lewin, R.¹

27
- 84912166005
- D. B. Caine, Ed. (Springer-Verlag, New York, in press)
- Handbook of Experimental Pharmacology: Drugs for Treatment of Parkinson's Disease
- Shoulson, I.¹

28
- 0004023753
- J. Jankovic and E. Tolosa, Eds Urban and Schwarzenberg, Baltimore-Munich
- (1988) Parkinson's Disease and Movement Disorders , pp. 75-85
- Langston, J.W.¹

29
- 0021009820
- (1983) J. Neural. Trans. Suppl. , vol.19 , pp. 89
- Cohen, G.¹

30
- 84941259060
- in press
- Ann. Neurol
- Cohen, G.¹ Spina, M.B.²

31
- 0024267460
- (1988) Mech. Ageing Dev. , vol.46 , pp. 237
- Knoll, J.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.